Klinic can connect you with a weight loss doctor near you to evaluate which prescription might be right for you
Use these tools and tips to broaden the impact of your article
What to expect during your first 3 months on GLP-1 medications
This confirms that the weight loss trajectory was indeed continuing beyond 48 weeks and provides evidence that the nadir had not been reached even at 68 weeks
Initially, the US Food and Drug Administration approved Wegovy, the brand name for a GLP-1-based medicine called semaglutide, for chronic weight management in June 2021
Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, et al